EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of new triazoloquinoxaline amine derivatives with potent modulatory effects against Toll-like receptor 7 through pharmacophore-based virtual screening and molecular docking approaches

Nasrin Saberi Harooni, Mohammad Reza Naimi-Jamal, Sajjad Gharaghani iD, Asal Katebi, Soheila Ajdary, Azar Tahghighi iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0336701 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Nasrin Saberi Harooni und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medicinal Chemistry Laboratory, Clinical Research Department, Pasteur Institute of Iran, Tehran, Iran. Hauptthemen laut MEDLINE: Toll-Like Receptor 7, Quinoxalines, Triazoles. Die Arbeit nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pasteur Institute of Iran.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Toll-like receptor 7 (TLR7) plays a key role in the signaling pathways involved in immunity by recognizing pathogen-associated molecular patterns. Due to its broad effectiveness in various diseases and the limited number of drugs on the market that act on this receptor, it remains an ideal target for pharmaceutical scientists. To find novel TLR7 ligands, chemical feature-based pharmacophore models were prepared for TLR7 using Pharmit. This model was used for virtual screening in related databases, and the identified compounds were ranked using the Autodock docking method and minimum binding affinity. Among the identified compounds, the triazoloquinoxaline amine scaffold was selected as the lead structure, and its different derivatives were designed and docked again. Finally, two new series of [1,2,4]triazolo[4,3-a]quinoxalin-4-amine and 1-methyl-[1,2,4]triazolo[4,3-a]quinoxalin-4-amine derivatives were selected and synthesized using green chemistry routes. The cytotoxicity of the synthetic compounds was assessed using a macrophage cell line, and non-toxic compounds were then selected for evaluating cytokine stimulation. Ultimately, compound 7f emerged as the most promising candidate for boosting the immune system based on fold change assessment compared to the control group. It exhibited the highest production of interleukin-1 (IL-1), tumor necrosis factor (TNF-α), and interferon beta (IFN-β) cytokines. Interestingly, the results of molecular docking aligned with the biological findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 7QuinoxalinesTriazolesMolecular Docking SimulationAnimalsHumansMiceLigandsDrug Evaluation, PreclinicalRAW 264.7 CellsPharmacophore

Substanzen

Toll-Like Receptor 7QuinoxalinesTriazolesLigands

Autor:innen und Institutionen

  • Medicinal Chemistry Laboratory, Clinical Research Department, Pasteur Institute of Iran, Tehran, Iran.
  • Department of Chemistry, Iran University of Science and Technology, Tehran, Iran.
  • Laboratory of Bioinformatics and Drug Design (LBD), Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
  • Department of Immunology, Pasteur Institute of Iran, Tehran, Iran.

ORCID-Profile: Sajjad Gharaghani, Azar Tahghighi

Förderung

  • Pasteur Institute of Iran

Zitieren

APA

Harooni, N. S., Naimi-Jamal, M. R., Gharaghani, S., Katebi, A., Ajdary, S., & Tahghighi, A. (2025). Identification of new triazoloquinoxaline amine derivatives with potent modulatory effects against Toll-like receptor 7 through pharmacophore-based virtual screening and molecular docking approaches. PLOS One. https://doi.org/10.1371/journal.pone.0336701

Vancouver

Harooni NS, Naimi-Jamal MR, Gharaghani S, Katebi A, Ajdary S, Tahghighi A. Identification of new triazoloquinoxaline amine derivatives with potent modulatory effects against Toll-like receptor 7 through pharmacophore-based virtual screening and molecular docking approaches. PLOS One. 2025. doi:10.1371/journal.pone.0336701

BibTeX
@article{Harooni2025,
  author = {Harooni, Nasrin Saberi and Naimi-Jamal, Mohammad Reza and Gharaghani, Sajjad and Katebi, Asal and Ajdary, Soheila and Tahghighi, Azar},
  title = {Identification of new triazoloquinoxaline amine derivatives with potent modulatory effects against Toll-like receptor 7 through pharmacophore-based virtual screening and molecular docking approaches},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0336701}
}
Kostenlos starten →